LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Trametinib | 10 | uM | LJP5 | 2 | P19 | 72 | hr | 1235 | 2540 | 4356 | 0.5831 | 0.4865 |
MCF7 | Trametinib | 10 | uM | LJP5 | 3 | P19 | 72 | hr | 1235 | 2549 | 4326 | 0.5892 | 0.4927 |
MCF7 | Omipalisib | 0.04 | uM | LJP6 | 1 | N06 | 72 | hr | 1235 | 1441 | 3974 | 0.3626 | 0.0956 |
MCF7 | Omipalisib | 0.04 | uM | LJP6 | 2 | N06 | 72 | hr | 1235 | 1257 | 4070 | 0.3088 | 0.0101 |
MCF7 | Omipalisib | 0.04 | uM | LJP6 | 3 | N06 | 72 | hr | 1235 | 1389 | 4126 | 0.3366 | 0.0697 |
MCF7 | Omipalisib | 0.12 | uM | LJP6 | 1 | N05 | 72 | hr | 1235 | 1340 | 3974 | 0.3372 | 0.0494 |
MCF7 | Omipalisib | 0.12 | uM | LJP6 | 2 | N05 | 72 | hr | 1235 | 1359 | 4070 | 0.3339 | 0.0570 |
MCF7 | Omipalisib | 0.12 | uM | LJP6 | 3 | N05 | 72 | hr | 1235 | 1392 | 4126 | 0.3373 | 0.0710 |
MCF7 | Omipalisib | 0.37 | uM | LJP6 | 1 | N04 | 72 | hr | 1235 | 1355 | 3974 | 0.3410 | 0.0564 |
MCF7 | Omipalisib | 0.37 | uM | LJP6 | 2 | N04 | 72 | hr | 1235 | 1422 | 4070 | 0.3494 | 0.0852 |
MCF7 | Omipalisib | 0.37 | uM | LJP6 | 3 | N04 | 72 | hr | 1235 | 1413 | 4126 | 0.3424 | 0.0803 |
MCF7 | Omipalisib | 1.11 | uM | LJP6 | 1 | N03 | 72 | hr | 1235 | 1303 | 3974 | 0.3279 | 0.0321 |
MCF7 | Omipalisib | 1.11 | uM | LJP6 | 2 | N03 | 72 | hr | 1235 | 1225 | 4070 | 0.3010 | -0.0049 |
MCF7 | Omipalisib | 1.11 | uM | LJP6 | 3 | N03 | 72 | hr | 1235 | 1056 | 4126 | 0.2559 | -0.0862 |
MCF7 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 1235 | 1123 | 3974 | 0.2826 | -0.0550 |
MCF7 | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 1235 | 1035 | 4070 | 0.2543 | -0.0978 |
MCF7 | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 1235 | 1003 | 4126 | 0.2431 | -0.1129 |
MCF7 | Omipalisib | 10 | uM | LJP6 | 1 | N01 | 72 | hr | 1235 | 827 | 3974 | 0.2081 | -0.2119 |
MCF7 | Omipalisib | 10 | uM | LJP6 | 2 | N01 | 72 | hr | 1235 | 853 | 4070 | 0.2096 | -0.1937 |
MCF7 | Omipalisib | 10 | uM | LJP6 | 3 | N01 | 72 | hr | 1235 | 788 | 4126 | 0.1910 | -0.2277 |
MCF7 | Buparlisib | 0.04 | uM | LJP5 | 1 | H06 | 72 | hr | 1235 | 3533 | 4119 | 0.8577 | 0.8309 |
MCF7 | Buparlisib | 0.04 | uM | LJP5 | 2 | H06 | 72 | hr | 1235 | 4064 | 4356 | 0.9329 | 0.9250 |
MCF7 | Buparlisib | 0.04 | uM | LJP5 | 3 | H06 | 72 | hr | 1235 | 4036 | 4326 | 0.9329 | 0.9246 |
MCF7 | Buparlisib | 0.12 | uM | LJP5 | 1 | H05 | 72 | hr | 1235 | 2628 | 4119 | 0.6380 | 0.5441 |
MCF7 | Buparlisib | 0.12 | uM | LJP5 | 2 | H05 | 72 | hr | 1235 | 2682 | 4356 | 0.6157 | 0.5317 |